DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Pfizer (NYSE: PFE)

company name or ticker
Company Photos
(Click to zoom)

3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015

Clinical-stage biotechs tend to bubble to the top of the list of best performing healthcare stocks. Here are three names to watch in 2015 and beyond.

Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest

The week before JPMorgan Healthcare conference brought a plethora of deals and data.

3 Pharma Stocks That Soared Past Pfizer in 2014 - Analyst Blog

2015 Dogs of the Dow: 10 Dividend Stocks You Should Watch This Year

This popular strategy is easy to follow and generates solid dividend income.

How Will Roche Perform In 2015?

What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

The Bullish and Bearish Case for Pfizer in 2015

Does AstraZeneca PLC Stock Offer a Golden Opportunity in 2015?

AstraZeneca would appear to be set to have a slow 2015. But that doesn't mean investors should sleep on this stock. Here's why.

Is Gilead Sciences Inc. Now a Takeover Target?

Gilead Sciences looks cheap based on its present valuation metrics and growth prospects going forward. Will a growth-starved big pharma decide to pursue a merger with this high flying biotech in 2015?

Update: Pfizer's Palbociclib Is Closer To Approval Than Expected